As the intense disruption and turmoil that emerged in 2020 plays out in 2021, life science organizations are further expanding new digital capabilities that enable business agility and flexibility. Despite this, many life science organizations still struggle with finding clarity on how to best deploy digital technology across the value chain, the scope and scale of technologies required, and the opportunities to support business transformation over the long term. This invitation-only, complimentary virtual briefing explores the major steps you must take to build your clinical and commercial IT strategy, deploy next-generation digital technologies to optimize clinical trials, and accelerate new drug launches. This includes building out capabilities in a more scalable fashion with a focus on data architectures, adaptability, and ecosystems. You also will learn how Gartner Digital Execution Scorecard helps you ensure you remain on the path of an impactful digital strategy.

1. RESTRICTED DISTRIBUTION
1 © 2021 Gartner, Inc. and/or its affiliates. All rights reserved.
Presenters
Animesh Gandhi,
Sr Director Analyst
Jeff Smith,
Sr Director Analyst
Barbara Adams,
Executive Partner
As the intense disruption and turmoil that emerged in 2020 plays out in 2021, life science
organizations are further expanding new digital capabilities that enable business agility and
flexibility. Despite this, many life science organizations still struggle with finding clarity on how
to best deploy digital technology across the value chain, the scope and scale of technologies
required, and the opportunities to support business transformation over the long term.
This invitation-only, complimentary virtual briefing explores the major steps you must take to
build your clinical and commercial IT strategy, deploy next generation digital technologies to
optimize clinical trials, and accelerate new drug launches. This includes building out
capabilities in a more scalable fashion with a focus on data architectures, adaptability, and
ecosystems. You also will learn how Gartner Digital Execution Scorecard helps you ensure
you remain on the path of an impactful digital strategy.
Discussion Topics:
▪ Develop strategic vision, approach and roadmap to adopt digital trials
▪ Leverage technologies and capabilities to stand out in an increasingly disrupted digital
environment
▪ Understand ways of executing digitalization in the clinical development and commercial
domains
Technologies to Improve Clinical Trials and
Commercialization
Virtual Briefing | June 9 | 11:00 AM EDT | On-Demand Available
If you would like to attend or have access to the On-Demand session recording,
please email clark.driz@gartner.com

2. RESTRICTED DISTRIBUTION
2 © 2021 Gartner, Inc. and/or its affiliates. All rights reserved.
Roles & Responsibilities
Animesh Gandhi's research focuses on Life Science (LS)
organizations critical commercial priorities. Mr. Gandhi helps
CIOs, and their teams leverage technology and best
practices to enable and optimize prelaunch planning,
marketing execution, campaign management, sales
enablement, market access, customer relationship
management, digital therapeutics, and revenue
management.
He also helps them with the associated information
management, master data management, analytics and AI
central to success in all LS commercial functions. His
research encompasses commercial IT strategy and vision,
multiyear roadmaps, reference architectures, vendor
evaluation, cost optimization, and business process
refinement, implementation approaches and support models.
Animesh Gandhi, Sr Director Analyst
Background
Mr. Gandhi has over 22 years of experience in the Life
Science industry, specializing in data, analytics, and
Information technology. He has been successful both
within and consulting to the LS industry working at the
intersection of business and technology. He has a deep
understanding of Life Science organizations commercial
business models and sources of competitive advantage.
Prior to joining Gartner, Mr. Gandhi led commercial
business technology at Otsuka Pharmaceuticals where he
successfully created and executed strategic technology
plans in support of the company's growth. He led
technology work streams for multiple product launches,
enhancing the company's commercial capabilities through
modernized technology platforms that extended the reach
and impact of digital channels and enabled centralized
information access to drive competitive advantage.
He also worked with digital therapeutics and marketing
teams to identify solutions that fulfill needs of the U.S.
market. Previously, he led an analytics and technology
division of a life sciences company and helped
organizations create and institute innovative analytical
decision-making processes and solutions in a vendor
product management role.
Issues I Help Clients Address
• Commercial IT Strategy and Execution
in Life Sciences
• Brand Marketing, Launch Planning,
and Market Access Execution in Life
Sciences
• Sales Force Management and
Operations in Life Sciences
• Data Management and Analytics in
Commercial Life Sciences
• Digital Therapeutics Development and
Commercialization
Examples of Research

3. RESTRICTED DISTRIBUTION
3 © 2021 Gartner, Inc. and/or its affiliates. All rights reserved.
Jeff Smith, Sr Director Analyst
Roles & Responsibilities
Jeff Smith is a Research Director on Gartner's Healthcare
and Life Sciences Industry Research team. Mr. Smith's
research is focused on clinical development activities
within pharmaceutical and medical device companies,
helping CIOs and R&D IT leaders to better navigate
strategic challenges and support their organization's
ability to manage product development from clinical trials
through regulatory approval.
He brings a unique combination of process, technical and
operations experience to life science research with his
background implementing enterprise solutions for
pharmaceutical R&D, role as a practitioner of continuous
process and technology improvement in clinical
development, and rich experience with quality and
regulatory processes.
Mr. Smith's vertical life science coverage specifically
includes clinical trials, regulatory submission, content
management, safety vigilance, quality and compliance
and related technologies (e.g., EDC, CTMS, IRT, eCTD,
RIM) for pharmaceuticals and other organizations that
support life science product development.
Background
Prior to joining Gartner, Mr. Smith spent his career in
pharmaceutical R&D, working in Clinical Operations, IT
Project Management, Clinical Quality and Regulatory
Affairs and Operations. He was a Global Operations
Manager at Forest Research Institute responsible for
Clinical Operations services and special projects, and
previous to this was a Project Manager leading process
and technology implementation projects for the
Informatics PMO. In his career, he has been a program,
product and process manager; software architect and
engineer (Java, Perl, C++, VB); validation specialist;
quality manager; system trainer; support manager and
business analyst.
Issues I Help Clients Address
• Improving clinical development
processes with new technology
• Continuous process improvement
within life science R&D
• Developing IT strategy in the highly
regulated pharmaceutical industry
• Understanding the software vendor
ecosystem within life science R&D
• Accelerating innovation in the R&D
information systems group
Examples of Research